AI-assisted education for migraine management
AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance
This study is testing if using AI to help educate people recently diagnosed with migraines can improve their understanding of the condition better than regular education.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 140 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ente Ospedaliero Cantonale, Bellinzona Academic / other |
| Locations | 1 site (Lugano) |
| Trial ID | NCT06507150 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of AI-assisted migraine education compared to standard education in improving patients' understanding of their condition. It focuses on individuals aged 18 to 65 who have recently been diagnosed with migraine. The intervention involves using AI technology to provide personalized educational content, enhancing engagement and knowledge retention. By leveraging AI, the study seeks to improve diagnosis, predict migraine episodes, and optimize treatment adherence, ultimately aiming to reduce the stigma associated with migraines.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who have recently been diagnosed with migraine and have access to digital devices.
Not a fit: Patients with cognitive impairments or those unable to use the AI-powered learning platform may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance patients' understanding and management of their migraines, leading to better health outcomes.
How similar studies have performed: While AI applications in healthcare are emerging, this specific approach to migraine education is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged between 18 and 65 years at the time of signing the informed consent * Newly diagnosis of migraine, confirmed through the medical chart * The participant must be capable of giving signed informed consent * Access to a laptop, computer, smartphone, or tablet Exclusion Criteria: * Insufficient knowledge of the protocol language (italian) * Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study. * Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage)
Where this trial is running
Lugano
- Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano — Lugano, Switzerland (Recruiting)
Study contacts
- Study coordinator: Giulia Mallucci, Prof. Dr.ssa med.
- Email: giulia.mallucci@eoc.ch
- Phone: +41 91 811 69 21
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.